2. Academic Validation
  3. Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptor

Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptor

  • Bioorg Med Chem Lett. 2005 Mar 1;15(5):1401-5. doi: 10.1016/j.bmcl.2005.01.003.
Joseph L Duffy 1,  Brian A Kirk,  Zenon Konteatis,  Elizabeth L Campbell,  Rui Liang,  Edward J Brady,  Mari Rios Candelore,  Victor D H Ding,  Guoqiang Jiang,  Frank Liu,  Sajjad A Qureshi,  Richard Saperstein,  Deborah Szalkowski,  Sharon Tong,  Lauri M Tota,  Dan Xie,  Xiaodong Yang,  Peter Zafian,  Song Zheng,  Kevin T Chapman,  Bei B Zhang,  James R Tata
Affiliations

Affiliation

  • 1 Department of Basic Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA. joseph_duffy@merck.com
PMID: 15713396 DOI: 10.1016/j.bmcl.2005.01.003
Abstract

A novel class of antagonists of the human Glucagon Receptor (hGCGR) has been discovered. Systematic modification of the lead compound identified substituents that were essential for activity and those that were amenable to further optimization. This SAR exploration resulted in the synthesis of 13, which exhibited good potency as an hGCGR functional antagonist (IC50 = 34 nM) and moderate bioavailability (36% in mice).

Figures
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z